Report Ocean has recently published the “Non-alcoholic Steatohepatitis (NASH) Diagnostics Market” Research Report 2023-2030, offering a comprehensive analysis of the market. This report delves deep into the market dynamics, including key trends, upcoming technologies, drivers, challenges, and regulatory policies. It also features company profiles and strategies of prominent players in the industry. With over 100+ market data tables, pie charts, graphs, and figures, this global market study provides a thorough understanding of the market landscape. It presents a complete assessment, encompassing future trends, current growth factors, informed opinions, factual insights, and industry-validated market data, enabling accurate forecasts until 2030.
Request To Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/IND109
The global epidemic of type 2 diabetes and rising obesity are leading to the growing prevalence of non-alcoholic steatohepatitis (NASH), especially in developed nations.
According to the NASH Education Program, NASH affects around 12% of the world’s adult population. More than 80% of patients with NASH are obese, 44% have type 2 diabetes, and 72% have abnormal blood lipids (triglycerides and cholesterol). The increasing prevalence of these ailments is expected to drive the demand for NASH diagnostics over the 2018-2023 period.
Programs and initiatives to increase awareness are anticipated to bolster market growth over the forecast period. In 2016, The NASH Education Program was established with the objective of spreading awareness among medical practitioners, patients identified with NASH, and individuals at high risk of developing it. On the other hand, rising investments for the development of accurate, reliable, and readily available diagnostic tests for NASH is expected to drive the market over the forecast period.
Diagnostic techniques segment insights:
Liver biopsy is one of the broadly accepted diagnostic techniques for NASH detection since it provides accurate results. Liver biopsy is preferred by medical practitioners owing to its ability to determine the degree of steatosis and inflammation accurately. However, the invasive liver biopsy procedure has several disadvantages, such as pain, bleeding, and the possibility of injuring other organs. Thus, the adoption of non-invasive imaging techniques and biomarkers is anticipated to increase significantly. As a result, the market size of the liver biopsy technique is expected to grow at a slower rate than biomarkers, in developed regions like North America and Europe.
Regional insights:
North America held the largest share of the NASH diagnostics market. The growing prevalence of obesity and type 2 diabetes is leading to an increasing number of patients suffering from NASH in the United States (U.S.) and Canada. NASH has been reported to be the second-most common cause for liver transplantations in the U.S. By 2020, it is expected to surpass hepatitis C as the leading cause for liver transplants. Asia-Pacific is expected to be the fastest growing market owing to increasing awareness among patients and improving healthcare infrastructure. However, the high cost of NASH diagnosis through liver biopsy is restraining the growth of the market in developing regions like Latin America and Asia-Pacific.
Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/IND109
Companies covered:
1. GENFIT SA
2. Echosens
3. SuperSonic Imagine
4. BioPredictive
5. One Way Liver, S.L. (OWL)
6. VLVbio AB
7. Quest Diagnostics Incorporated
8. Prometheus Laboratories Inc.
9. Siemens Healthcare GmbH.
10. Exalenz Bioscience Ltd.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
Request full Report Description, TOC, Table of Figure, Chart, etc. @ –https://reportocean.us/sample-request/report_id/IND109
The report addresses the following key questions regarding the Non-alcoholic Steatohepatitis (NASH) Diagnostics market:
- What is the expected growth rate of the market in the upcoming years and what factors are driving this growth?
- How do consumers perceive and adopt different types of Non-alcoholic Steatohepatitis (NASH) Diagnostics in the market?
- How are regulatory policies and government initiatives impacting the growth of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What is the market share of the top 5 players in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market and how is it likely to change in the future?
- What are the latest technologies and innovations in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market and how are they shaping the industry landscape?
- How do macroeconomic factors such as inflation, GDP, and exchange rates affect the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What are the challenges related to the supply chain and logistics that Non-alcoholic Steatohepatitis (NASH) Diagnostics market players face and how are they addressing them?
- How is the changing consumer behavior and preferences influencing the dynamics of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What are the potential risks and uncertainties associated with investing in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market, and how can they be mitigated?
Reasons to Buy This Report
(A) The research provides valuable insights for top administration, policymakers, professionals, product advancements, sales managers, and stakeholders in the market. It helps them make informed decisions and strategize effectively.
(B) The report offers comprehensive analysis of Non-alcoholic Steatohepatitis (NASH) Diagnostics market revenues on a global, regional, and country level, projecting trends until 2030. This data allows companies to assess their market share, identify growth opportunities, and explore new markets.
(C) The research includes segmentation of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market based on types, applications, technologies, and end-uses. This segmentation enables leaders to plan their products and allocate resources based on the expected growth rates of each segment.
(D) Analysis of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market benefits investors by providing insights into market scope, position, key drivers, challenges, restraints, expansion opportunities, and potential threats. This information helps them make informed investment decisions.
(E) The report offers a detailed analysis of competitors, their key strategies, and market positioning. This knowledge allows businesses to better understand the competition and plan their own strategies accordingly.
(F) The study helps evaluate Non-alcoholic Steatohepatitis (NASH) Diagnostics business predictions by region, key countries, and top companies, providing valuable information for investment planning and decision-making.
Request Full Report –https://reportocean.us/sample-request/report_id/IND109
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1 888 212 3539 (US – TOLL FREE)
Website: https://reportocean.us/